Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Public and private sectors team up to develop new antimalarial drugs

Jan. 27, 1999

Hokuriku Seiyaku presents broad-spectrum antibacterial agents with good safety

Jan. 26, 1999

Licensing opportunity from NIH: monomeric and dimeric arylisoquinoline alkaloids

Jan. 26, 1999

Pfizer's new macrolide antibiotics presented in patent literature

Jan. 25, 1999

PAP mutants licensed by Hughes Institute; potential anticancer and antiviral therapies

Jan. 22, 1999

Genome Therapeutics first milestone in alliance with Schering-Plough

Jan. 21, 1999

Pfizer launches Trovan in Canada

Jan. 20, 1999

Results from large study comparing atovaquone and dapsone for PCP prophylaxis published

Jan. 19, 1999

New broad-spectrum antibacterial series patented by Bayer

Jan. 19, 1999

MIST study provides further evidency of zanamivir's efficacy and safety

Jan. 18, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 11, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 11, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.